LifeMD launches exclusive XYOSTED telehealth co-marketing program in July 2026
LifeMD announced an exclusive collaboration with Antares Pharma to offer a direct-to-patient self-pay program for XYOSTED testosterone injection, launching in 37 states at $249/month including care and medication. The partnership leverages LifeMD's virtual care platform and pharm
View filing at SEC.gov →